24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Derek Marsee is a pathologist based in Sacramento, California. He has been in practice for the past 12 years. Dr. Marsee graduated from the Ohio State University College of Medicine. He completed his residency at the Brigham and Women's Hospital followed by two fellowship stages at the Beth Israel Deaconess Medical Center and the Brigham and Women's Hospital. Dr. Marsee is board-certified in three clinical areas: Anatomic Pathology, Hematology, and Dermatopathology. He has been active in the research field as well and he has contributed to multiple published studies. Some of the subjects he discussed in his publications include bone marrow biopsy, clonal plasma cells assaying techniques, follicular dendritic cells, and Podoplanin as a marker. Dr. Marsee is licensed to practice medicine in California and Nevada. He is currently affiliated with the Sutter Roseville Medical Center, the Mercy General Hospital, and the Sutter Auburn Faith Hospital.
AetnaAetna Choice POS IIAetna HMOBlue Shield of CaliforniaCignaFirst Health PPOHealth NetMultiPlanUnited Healthcare
The Ohio State University College of Medicine
Medical School
Brigham and Women\'s Hospital
Residency
Brigham and Women\'s Hospital
Fellowship
Beth Israel Deaconess Medical Center
Fellowship
American Board of Pathology
CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.
Marsee, D.K., Pinkus, G.S., Yu, H.; Am J Clin Pathol. 2010 Sep.
See more >>Single tube, six-color flow cytometric analysis is a sensitive and cost-effective technique for assaying clonal plasma cells.
Marsee, D.K., Li, B., Dorfman, D.M.; Am J Clin Pathol. 2010 May.
See more >>Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells.
Marsee, D.K., Pinkus, G.S., Hornick, J.L.; Appl Immunohistochem Mol Morphol. 2009-03-01.
See more >>